Regular blood testing to check for toxicity from standard rheumatoid arthritis drugs is recommended. Results of this ...

Across 99 studies examining the effects of high-concentration THC products on mental health outcomes, 70% of the ...

The PCSK9 inhibitor evolocumab (Repatha) got the FDA's blessing for cardiovascular protection, with or without a history of cardiovascular disease (CVD).

In a fact sheet, the agency noted that high concentrations of oxygen pose a risk for fire, "which is one reason why the FDA recommends treatment at an accredited facility. Explosions and fires have ...